MARKET WIRE NEWS

Overweight Recommendation Issued On BIOVF By Barclays

Source: KlickAnalytics

2026-02-24 12:15:05 ET

  • Barclays analyst issues OVERWEIGHT recommendation for BIOVF on February 24, 2026 05:09PM ET.
  • The previous analyst recommendation was Overweight.
  • BIOVF was trading at $37 at issue of the analyst recommendation.
  • The overall analyst consensus : HOLD.
  • Current analyst recommendations are : 1 - Hold recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations < ...
    Full story available on KlickAnalytics.com
    Swedish Orphan Biovit Ord

    NASDAQ: BIOVF

    BIOVF Trading

    -2.12% G/L:

    $41.32 Last:

    345 Volume:

    $42.215 Open:

    mwn-ir Ad 300

    BIOVF Latest News

    BIOVF Stock Data

    $13,111,281,002
    354,358,946
    N/A
    N/A
    Pharmaceuticals
    Healthcare
    SE

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App